Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma
Main Authors: | Ling-ling Fu, Ming Yan, Min-Xian Ma, Yi Luo, Min Shao, Martin Gosau, Reinhard E. Friedrich, Tobias Vollkommer, Hong-chao Feng, Ralf Smeets |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1099835/full |
Similar Items
-
DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
by: Ling-ling Fu, et al.
Published: (2022-07-01) -
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
by: Pan Xie, et al.
Published: (2022-08-01) -
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-03-01) -
DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
by: Xiaosu Chen, et al.
Published: (2021-03-01) -
Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression
by: Qingfei Meng, et al.
Published: (2024-01-01)